Physician profile
Blythe Demello
NPI 1558002675
$6,182.91
in general payments reported to CMS, 2019-2025
53 companies · $2,697 in 2025
The $2,697 reported for 2025 was more than what 99% of Critical Care Medicine (Registered Nurse) providers received nationally (typical 2025 total: $51.32).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $892 · 2024: $2,594 · 2025: $2,697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,902 · Education: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,901.93 |
| Education | $280.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $731.18 | 2023-2025 | Lynparza, Imfinzi, Enhertu |
| Pfizer INC. | $633.85 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $503.96 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $432.77 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Glaxosmithkline, LLC. | $272.24 | 2023-2025 | Jemperli, Ojjaara, Zejula |
| Abbvie INC. | $264.68 | 2023-2025 | |
| Celgene Corporation | $263.87 | 2023-2025 | Reblozyl, Pomalyst |
| Takeda Pharmaceuticals U.S.A., INC. | $239.71 | 2023-2025 | Fruzaqla, Iclusig, Alunbrig |
| Janssen Biotech, INC. | $179.24 | 2023-2024 | Imbruvica, Rybrevant, Carvykti |
| Bayer Healthcare Pharmaceuticals INC. | $177.96 | 2023-2025 | |
| Seagen INC. | $174.53 | 2023-2025 | Tukysa, Adcetris |
| Pharmacosmos Therapeutics INC. | $153.30 | 2023-2025 | Monoferric |
| Incyte Corporation | $151.14 | 2023-2025 | Jakafi, Monjuvi, Zynyz |
| Sumitomo Pharma America, INC. | $142.52 | 2024-2025 | Orgovyx |
| Gilead Sciences, INC. | $129.33 | 2024-2025 | Trodelvy |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $123.07 | 2024-2025 | |
| Daiichi Sankyo INC. | $119.81 | 2024-2025 | Vanflyta, Enhertu |
| Emd Serono, INC. | $118.01 | 2024-2025 | |
| Sobi, INC | $114.91 | 2024-2025 | |
| Genzyme Corporation | $96.42 | 2023-2025 | |
| Exelixis INC. | $87.61 | 2023-2025 | Cabometyx |
| Beone Medicines USA, INC. | $82.27 | 2025 | Tevimbra |
| Aveo Pharmaceuticals, INC. | $81.82 | 2023-2025 | Fotivda |
| Astellas Pharma US INC | $62.53 | 2024-2025 | Vyloy |
| Karyopharm Therapeutics INC. | $53.77 | 2023-2025 | Xpovio |
| Ipsen Biopharmaceuticals, INC | $52.44 | 2024-2025 | Onivyde |
| Tempus Ai, INC | $47.48 | 2025 | Xt Cdx |
| Progenics Pharmaceuticals, INC. | $46.60 | 2023-2024 | Pylarify |
| Amneal Pharmaceuticals LLC | $39.72 | 2024-2025 | Neupogen, Neulasta, Avastin |
| Coherus Oncology, INC. | $39.17 | 2023-2025 | Loqtorzi |
| Stemline Therapeutics INC. | $38.48 | 2023 | Orserdu |
| Mirati Therapeutics, INC. | $36.35 | 2023 | Krazati |
| Octapharma USA, INC. | $35.75 | 2024 | Octagam Immune Globulin (Human) |
| Amgen INC. | $34.08 | 2023-2024 | Kyprolis, Blincyto |
| Alnylam Pharmaceuticals INC. | $32.23 | 2025 | Givlaari |
| Geron Corporation | $31.23 | 2025 | Rytelo |
| Genmab U.S., INC. | $30.72 | 2025 | Tivdak |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.36 | 2023 | Gilotrif |
| Deciphera Pharmaceuticals INC. | $26.90 | 2024 | Qinlock |
| Azurity Pharmaceuticals, INC. | $24.68 | 2025 | Danziten |
| Acrotech Biopharma INC. | $23.78 | 2025 | Beleodaq |
| Myriad Genetic Laboratories, INC. | $23.78 | 2024 | Myrisk |
| Rigel Pharmaceuticals, INC. | $22.37 | 2025 | Tavalisse, Gavreto, Rezlidhia |
| Alexion Pharmaceuticals, INC. | $22.36 | 2024 | Ultomiris |
| E.R. Squibb & Sons, L.L.C. | $21.52 | 2025 | Opdivo |
| Regeneron Healthcare Solutions, INC. | $20.99 | 2025 | Libtayo |
| Eisai INC. | $18.35 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $18.07 | 2024 | Truxima |
| Beigene USA, INC. | $17.37 | 2024 | Brukinsa |
| Springworks Therapeutics, INC. | $15.89 | 2025 | Gomekli |
| Adaptive Biotechnologies Corporation | $15.00 | 2025 | |
| Aimmune Therapeutics, INC. | $14.26 | 2025 | Zenpep |
| Pharmaessentia USA Corporation | $13.48 | 2025 | Besremi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blythe Demello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.